|
Response to current chemotherapy with regard to previous chemotherapy regimens, response to previous chemotherapy, and current chemotherapy regimen (combination or monotherapy). |
|||||||||
| Numbers of previous chemotherapy regimens |
Response to previous chemotherapy |
Current chemotherapy regimen |
|||||||
|
|
|||||||||
| Response to current chemotherapy |
1 |
2 |
3 |
4 |
PR |
SD |
PD |
Oxaliplatin and gemcitabine |
Oxaliplatin |
|
|
|||||||||
| Partial response |
2 |
0 |
0 |
0 |
0 |
1 |
1 |
2 |
0 |
|
|
|||||||||
| Stable disease |
6 |
5 |
0 |
0 |
0 |
3 |
8 |
10 |
1 |
|
|
|||||||||
| Progressive disease |
7 |
5 |
3 |
1 |
0 |
3 |
13 |
13 |
3 |
Xanthopoulos et al. Journal of Occupational Medicine and Toxicology 2008 3:34 doi:10.1186/1745-6673-3-34 |
|||||||||